文献速递眼底病与葡萄膜炎

超广角荧光素眼底血管造影识别的视网膜非灌注与糖尿病视网膜病变随时间恶化的关联

Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time.
PubMed 文献 · JAMA Ophthalmol · 2022-01-01

这项前瞻性多中心纵向观察性队列研究纳入508只眼,评估基线超广角荧光素眼底血管造影(UWF-FA)所识别的视网膜非灌注范围与位置是否与糖尿病视网膜病变严重程度量表(DRSS)评分恶化或需治疗相关。结果显示,校正基线DRSS后,总体非灌注指数(NPI)、后极部NPI和中周部NPI更高均与4年内疾病恶化风险更高相关;多变量分析中,更高NPI和存在UWF-FA上 predominantly peripheral lesions(FA PPL)仍与疾病恶化相关。

要点

  • 校正基线DRSS后,总体NPI每增加0.1单位,4年内疾病恶化风险HR为1.11(95%CI 1.02-1.21;P=.02)。
  • 后极部NPI每增加0.1单位,疾病恶化风险HR为1.35(95%CI 1.17-1.56;P<.001)。
  • 多变量分析中,FA PPL存在与疾病恶化相关,HR为1.89(95%CI 1.35-2.65;P<.001)。

核心结论

  • 基线视网膜非灌注范围更大和UWF-FA上存在FA PPL均与糖尿病视网膜病变恶化风险更高相关,即使校正基线DRSS评分和已知全身危险因素后仍存在关联。

研究设计与样本

  • 前瞻性、多中心、纵向观察性队列研究,纳入508只基线有非增殖性糖尿病视网膜病变且UWF-FA非灌注可分级眼。
  • 所有图像在中心阅读中心分级;基线及每年一次共4年分级200°超广角彩色图像以评估DR。
  • 基线200° UWF-FA图像分级非灌注面积、非灌注指数(NPI)和UWF-FA上 predominantly peripheral lesions(FA PPL)是否存在。
  • 糖尿病视网膜病变或糖尿病黄斑水肿的治疗由研究者自行决定。

主要发现

  • 校正基线DRSS后,总体NPI每增加0.1单位,4年内疾病恶化风险HR为1.11(95%CI 1.02-1.21;P=.02)。
  • 校正基线DRSS后,后极部NPI每增加0.1单位,疾病恶化风险HR为1.35(95%CI 1.17-1.56;P<.001)。
  • 校正基线DRSS后,中周部NPI每增加0.1单位,疾病恶化风险HR为1.08(95%CI 1.00-1.16;P=.04)。
  • 多变量分析校正基线DRSS评分和基线全身危险因素后,更高NPI与疾病恶化相关(HR 1.11;95%CI 1.02-1.22;P=.02)。
  • 多变量分析校正基线DRSS评分和基线全身危险因素后,FA PPL存在与疾病恶化相关(HR 1.89;95%CI 1.35-2.65;P<.001)。

关键数值与推荐

  • 疾病恶化定义为超广角彩色图像上Early Treatment Diabetic Retinopathy Study区域内DRSS恶化≥2级或接受DR治疗。

临床怎么用

  • 作者认为,疾病恶化与视网膜非灌注和FA PPL之间的关联支持在未来的DR预后、临床照护和研究中增加使用UWF-FA以补充彩色眼底照相。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Presence of predominantly peripheral diabetic retinopathy (DR) lesions on ultra-widefield fluorescein angiography (UWF-FA) was associated with greater risk of DR worsening or treatment over 4 years. Whether baseline retinal nonperfusion assessment is additionally predictive of DR disease worsening is unclear. OBJECTIVE: To assess whether the extent and location of retinal nonperfusion identified on UWF-FA are associated with worsening in Diabetic Retinopathy Severity Scale (DRSS) score or DR treatment over time. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was a prospective, multicenter, longitudinal observational study with data for 508 eyes with nonproliferative DR and gradable nonperfusion on UWF-FA at baseline. All images were graded at a centralized reading center; 200° ultra-widefield (UWF) color images were graded for DR at baseline and annually for 4 years. Baseline 200° UWF-FA images were graded for nonperfused area, nonperfusion index (NPI), and presence of predominantly peripheral lesions on UWF-FA (FA PPL). INTERVENTIONS: Treatment of DR or diabetic macular edema was at investigator discretion. MAIN OUTCOMES AND MEASURES: Association of baseline UWF-FA nonperfusion extent with disease worsening, defined as either 2 or more steps of DRSS worsening within Early Treatment Diabetic Retinopathy Study fields on UWF-color images or receipt of DR treatment. RESULTS: After adjusting for baseline DRSS, the risk of disease worsening over 4 years was higher in eyes with greater overall NPI (hazard ratio [HR] for 0.1-unit increase, 1.11; 95% CI, 1.02-1.21; P = .02) and NPI within the posterior pole (HR for 0.1-unit increase, 1.35; 95% CI, 1.17-1.56; P < .001) and midperiphery (HR for 0.1-unit increase, 1.08; 95% CI, 1.00-1.16; P = .04). In a multivariable analysis adjusting for baseline DRSS score and baseline systemic risk factors, greater NPI (HR, 1.11; 95% CI, 1.02-1.22; P = .02) and presence of FA PPL (HR, 1.89; 95% CI, 1.35-2.65; P < .001) remained associated with disease worsening. CONCLUSIONS AND RELEVANCE: This 4-year longitudinal study has demonstrated that both greater baseline retinal nonperfusion and FA PPL on UWF-FA are associated with higher risk of disease worsening, even after adjusting for baseline DRSS score and known systemic risk. These associations between disease worsening and retinal nonperfusion and FA PPL support the increased use of UWF-FA to complement color fundus photography in future efforts for DR prognosis, clinical care, and research.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Silva PS, Marcus DM, Liu D, et al. Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time. JAMA Ophthalmol. 2022. PMID: 35980610. doi:10.1001/jamaophthalmol.2022.3130

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。